Original language | English |
---|---|
Pages (from-to) | 935-939 |
Number of pages | 5 |
Journal | Japanese Journal of Cancer and Chemotherapy |
Volume | 42 |
Issue number | 8 |
Publication status | Published - Aug 1 2015 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Medicine(all)
Cite this
II. Development and future prospects of the third-generation EGFR-tyrosine kinase inhibitor. / Sakata, Shinya; Iwama, Eiji; Okamoto, Isamu.
In: Japanese Journal of Cancer and Chemotherapy, Vol. 42, No. 8, 01.08.2015, p. 935-939.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - II. Development and future prospects of the third-generation EGFR-tyrosine kinase inhibitor
AU - Sakata, Shinya
AU - Iwama, Eiji
AU - Okamoto, Isamu
PY - 2015/8/1
Y1 - 2015/8/1
UR - http://www.scopus.com/inward/record.url?scp=84978382729&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84978382729&partnerID=8YFLogxK
M3 - Article
C2 - 26353390
AN - SCOPUS:84978382729
VL - 42
SP - 935
EP - 939
JO - Japanese Journal of Cancer and Chemotherapy
JF - Japanese Journal of Cancer and Chemotherapy
SN - 0385-0684
IS - 8
ER -